Information for Shareholders and Investors

Latest news and press releases

  • 05 may, 2016

    Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division Download (256.2 Kb)

  • 08 mar, 2016

    Grifols will invest USD 360M to expand its manufacturing capacities for plasma-derived therapies Download (240.1 Kb)

  • 29 feb, 2016

    Grifols’ revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million Download (347.1 Kb)